Position in HLN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$535,184
New position
Shares Held
53,465
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CIBC Asset Management Inc holds $45,054,973 across 12 Drug Manufacturers - Specialty & Generic names. HLN ranks #7 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
270,642 | $31,992,590 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
148,384 | $4,469,326 | |
| 3 | VTRS |
Viatris Inc
|
257,647 | $3,480,810 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,465 | $1,461,695 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
250,795 | $1,354,293 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
5,544 | $730,366 | |
| 7 | HLN |
Haleon plc
This page
|
53,465 | $535,184 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
15,695 | $375,581 |
All Filings in HLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $535,184 | 53,465 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||